ARCHIVES

In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List

This article is from The Cancer Letter archive.

Vol. 06 No. 21 | May 23, 1980

Download PDF Visit The Full Archive

Related Articles

Zevalin Regimen Better Than Rituximab Alone For NHL

June 29, 2001

Skipper To Receive Bristol-Myers Award

March 14, 1980

Program Project Scores Have Compressed Review Shuld Return To Rank Order; Broder

October 2, 1992

Cooperative Group Competing Renewals May Be Funded Only at 70-80% Of Amounts Recommended By CCIRC

January 2, 1981

Panel Says NIH Must Devise Means For Early Release Of Trials Data

January 25, 1991

Health Professional Training Needs Improvement, IOM Says.

July 4, 2003